VISIOPHARM A/S
CVR number: 26186676
Agern Alle 24, 2970 Hørsholm
tel: 88202088
Income statement (mDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 87.92 | 84.26 | 108.50 | 135.97 | 112.09 |
| Other operating income | 0.59 | 0.03 | 0.07 | ||
| Purchases during the financial year | -32.06 | -20.14 | -41.63 | -51.84 | -25.36 |
| External services | -22.18 | -20.17 | -21.58 | -30.61 | -22.91 |
| Gross profit | 33.67 | 44.55 | 66.86 | 84.16 | 86.81 |
| Employee benefit expenses | -52.62 | -64.73 | -83.74 | -72.62 | -78.39 |
| Total depreciation | -4.36 | -8.92 | -7.76 | -8.74 | -9.59 |
| EBIT | -23.30 | -29.11 | -46.22 | -27.80 | -24.08 |
| Other financial income | 0.44 | 0.04 | 0.58 | 4.48 | 0.61 |
| Other financial expenses | -0.88 | -2.67 | -1.09 | -1.00 | -5.06 |
| Pre-tax profit | -23.75 | -31.75 | -46.73 | -24.33 | -28.53 |
| Income taxes | 2.06 | 5.44 | 5.39 | 3.71 | -1.76 |
| Net earnings | -21.69 | -26.31 | -41.34 | -20.61 | -30.29 |
Assets (mDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible rights | 4.86 | 4.46 | 5.07 | 7.86 | 8.77 |
| Goodwill | 9.73 | 9.73 | 9.73 | 9.73 | 9.73 |
| Intangible assets total | 14.59 | 14.18 | 14.80 | 17.59 | 18.50 |
| Machinery and equipment | 0.67 | 0.71 | |||
| Other tangible assets | 0.76 | 1.47 | 0.91 | ||
| Tangible assets total | 0.67 | 0.71 | 0.76 | 1.47 | 0.91 |
| Other non-current investments | 9.73 | 13.85 | 13.85 | 14.02 | 15.82 |
| Investments total | 9.73 | 13.85 | 13.85 | 14.02 | 15.82 |
| Non-current other receivables | 0.43 | 0.38 | |||
| Deferred tax assets | 1.18 | 5.49 | 9.75 | 11.91 | 8.77 |
| Long term receivables total | 1.61 | 5.86 | 9.75 | 11.91 | 8.77 |
| Inventories total | 1.00 | 1.40 | 0.20 | 0.18 | 3.24 |
| Current trade debtors | 21.45 | 23.45 | 30.16 | 17.56 | 19.74 |
| Current owed by particip. interest comp. | 0.75 | ||||
| Prepayments and accrued income | 0.22 | 0.51 | 5.63 | 4.98 | 9.56 |
| Current other receivables | 0.70 | 0.52 | 0.78 | 0.33 | |
| Current deferred tax assets | 2.45 | 2.00 | 3.54 | 3.87 | 3.98 |
| Short term receivables total | 24.82 | 27.23 | 40.12 | 26.75 | 33.27 |
| Cash and bank deposits | 63.06 | 90.95 | 54.09 | 35.68 | 48.49 |
| Cash and cash equivalents | 63.06 | 90.95 | 54.09 | 35.68 | 48.49 |
| Balance sheet total (assets) | 115.48 | 154.19 | 133.56 | 107.60 | 129.00 |
Equity and liabilities (mDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 1.41 | 1.63 | 1.63 | 1.63 | 1.70 |
| Other reserves | -0.73 | 0.21 | -0.44 | -5.66 | -3.25 |
| Retained earnings | 98.13 | 124.94 | 99.56 | 58.55 | 57.32 |
| Profit of the financial year | -21.69 | -26.31 | -41.34 | -20.61 | -30.29 |
| Shareholders equity total | 77.11 | 100.47 | 59.41 | 33.90 | 25.48 |
| Non-current loans from credit institutions | 1.20 | 14.98 | 33.77 | ||
| Non-current leasing loans | 2.41 | 0.91 | 0.67 | 2.15 | |
| Non-current accruals and deferred income | 0.30 | 1.88 | |||
| Non-current other liabilities | 5.10 | 3.17 | 2.13 | 3.69 | 5.88 |
| Non-current liabilities total | 5.40 | 7.46 | 4.23 | 19.34 | 41.79 |
| Current loans from credit institutions | 1.81 | 1.94 | 2.09 | 1.06 | 0.30 |
| Current leasing loans | 1.89 | 1.63 | 1.92 | 2.26 | |
| Advances received | 1.05 | 1.73 | 1.55 | 1.06 | 1.22 |
| Current trade creditors | 12.23 | 6.00 | 13.34 | 2.36 | 10.18 |
| Other non-interest bearing current liabilities | 13.03 | 24.02 | 32.03 | 19.24 | 16.98 |
| Accruals and deferred income | 4.84 | 10.69 | 19.29 | 28.71 | 30.78 |
| Current liabilities total | 32.97 | 46.26 | 69.92 | 54.35 | 61.72 |
| Balance sheet total (liabilities) | 115.48 | 154.19 | 133.56 | 107.60 | 129.00 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.